Does BISOPROLOL Cause Hyperleukocytosis? 24 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Hyperleukocytosis have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.1% of all adverse event reports for BISOPROLOL.
24
Reports of Hyperleukocytosis with BISOPROLOL
0.1%
of all BISOPROLOL reports
5
Deaths
24
Hospitalizations
How Dangerous Is Hyperleukocytosis From BISOPROLOL?
Of the 24 reports, 5 (20.8%) resulted in death, 24 (100.0%) required hospitalization, and 6 (25.0%) were considered life-threatening.
Is Hyperleukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does BISOPROLOL Cause?
Dyspnoea (2,940)
Bradycardia (2,535)
Hypotension (2,504)
Dizziness (2,153)
Fall (2,011)
Fatigue (1,983)
Acute kidney injury (1,894)
Malaise (1,602)
Drug ineffective (1,486)
Nausea (1,460)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
ARSENIC TRIOXIDE (49)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
Which BISOPROLOL Alternatives Have Lower Hyperleukocytosis Risk?
BISOPROLOL vs BISOPROLOL\BISOPROLOL
BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE
BISOPROLOL vs BIVALIRUDIN
BISOPROLOL vs BLEOMYCIN
BISOPROLOL vs BLINATUMOMAB